Sigbjørn Berentsen Selected Research

ibrutinib

11/2021

Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sigbjørn Berentsen Research Topics

Disease

33	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 12/2023 - 04/2004
17	Hemolysis 05/2023 - 06/2014
6	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2023 - 03/2014
5	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 11/2019 - 01/2015
4	Fatigue 01/2023 - 01/2021
3	Infections 01/2023 - 05/2012
3	Anemia 01/2023 - 11/2009
3	Hemolytic Anemia 11/2021 - 01/2019
2	Neoplasms (Cancer) 06/2015 - 05/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 03/2014 - 09/2007
1	Neutropenia 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Rhinitis 01/2022
1	Raynaud Disease (Raynaud's Disease) 01/2022
1	Headache (Headaches) 01/2022
1	Long Term Adverse Effects 01/2020
1	Multiple Myeloma 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018
1	Acute-Phase Reaction 05/2017
1	Lymphoma (Lymphomas) 03/2014
1	Hemochromatosis (Bronze Diabetes) 01/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2012
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2009
1	Cytopenia 12/2007
1	Thrombosis (Thrombus) 09/2002
1	Pulmonary Embolism 09/2002

Drug/Important Bio-Agent (IBA)

16	Complement System Proteins (Complement)IBA 05/2023 - 06/2014
9	AgglutininsIBA 11/2021 - 03/2009
8	Rituximab (Mabthera)FDA Link 01/2020 - 04/2004
5	sutimlimabIBA 05/2023 - 01/2021
5	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2021
5	cold agglutininsIBA 01/2020 - 09/2007
4	AutoantibodiesIBA 12/2023 - 09/2007
4	Monoclonal AntibodiesIBA 01/2023 - 06/2014
3	Bendamustine Hydrochloride FDA Link 01/2023 - 01/2017
2	Immunoglobulin M (IgM)IBA 12/2023 - 01/2020
2	BilirubinIBA 01/2023 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 11/2009
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	Complement Inactivating AgentsIBA 01/2023 - 10/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2016
2	fludarabineIBA 01/2020 - 10/2010
2	Surface Antigens (Surface Antigen)IBA 05/2017 - 09/2007
1	Complement Receptors (Complement Receptor)IBA 12/2023
1	I-antigenIBA 12/2023
1	Complement C1s (C1 Esterase)IBA 01/2023
1	ibrutinibIBA 11/2021
1	daratumumabIBA 10/2020
1	AntibodiesIBA 01/2020
1	AntigensIBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	eculizumab FDA Link 05/2017
1	TNT003IBA 06/2014
1	Blood Group Antigens (Blood Groups)IBA 03/2014
1	Ferritins (Ferritin)IBA 01/2014
1	IronIBA 09/2012

Therapy/Procedure

20	Therapeutics 01/2023 - 09/2002
2	Drug Therapy (Chemotherapy) 01/2018 - 11/2009
1	Radiotherapy 01/2018
1	Blood Component Removal (Apheresis) 01/2014
1	Chelation Therapy (Therapy, Chelation) 09/2012
1	Aftercare (After-Treatment) 04/2004
1	Thrombolytic Therapy 09/2002
1	Catheters 09/2002